CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,724,648
- in 7 filings, $2.7M under 10b5-1 plans
Net −$2,724,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,635 | $4.14 | $7K | 5,229 |
| 2025-12-16 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,635 | $10.90 | $18K | 3,594 |
| 2025-12-16 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,635 | 73,595 | ||
| 2025-12-12 | THEUER CHARLES Director | Option exercise | +9,333 | $1.14 | $11K | 41,684 |
| 2025-12-12 | THEUER CHARLES Director | Option exercise · Stock Option (Right to Buy) | −9,333 | 0 | ||
| 2025-12-09 | Humer Kristian Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +480,000 | 480,000 | ||
| 2025-11-17 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,635 | $4.14 | $7K | 5,229 |
| 2025-11-17 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,635 | $10.59 | $17K | 3,594 |
| 2025-11-17 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,635 | 75,230 | ||
| 2025-10-24 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,084 | $6.49 | $7K | 6,272 |
| 2025-10-24 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −2,678 | $12.00 | $32K | 3,594 |
| 2025-10-24 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,084 | 9,295 | ||
| 2025-10-16 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,635 | $4.14 | $7K | 6,823 |
| 2025-10-16 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,635 | $10.17 | $17K | 5,188 |
| 2025-10-16 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,635 | 76,865 | ||
| 2025-10-09 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −2,408 | $10.00 | $24K | 5,188 |
| 2025-09-23 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −2,407 | $8.00 | $19K | 7,596 |
| 2025-06-17 | Chacko Jacob Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2025-06-17 | GRAY SUSANNAH Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2025-06-17 | Tomasello Shawn Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 |
Page 4 of 16 · 319 trades